BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Oxymetazoline

A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)

298+ PubMed studies analyzed · 58 RCTs · Evidence Score: 51

Research Domains

Oxymetazoline has been studied across 17 research domains including 🫁 Respiratory, 🧠 Focus & Attention, ✨ Skin & Hair, ❤️ Cardiovascular, 😴 Sleep. The primary research focus is 🫁 Respiratory with 8% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Oxymetazoline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Ergotamine
19 shared targets
Pergolide
21 shared targets
Dexmedetomidine
13 shared targets
Guanfacine
15 shared targets
Dihydroergotamine
22 shared targets
Phentolamine
18 shared targets
Yohimbine
20 shared targets
Clonidine
15 shared targets
Lisuride
19 shared targets
Quetiapine
22 shared targets
Loading evidence profile...

This evidence profile for Oxymetazoline is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.